Lenalidomide in Combination With Rituximab in Treating Participants With Stage III/IV Indolent Non-Hodgkin Lymphoma

NCT00695786 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

156

Enrollment

OTHER

Sponsor class

Conditions

Ann Arbor Stage III Grade 1 Follicular Lymphoma
Ann Arbor Stage III Grade 2 Follicular Lymphoma
Ann Arbor Stage III Indolent Adult Non-Hodgkin Lymphoma
Ann Arbor Stage III Marginal Zone Lymphoma
Ann Arbor Stage III Small Lymphocytic Lymphoma
Ann Arbor Stage IV Grade 1 Follicular Lymphoma
Ann Arbor Stage IV Grade 2 Follicular Lymphoma
Ann Arbor Stage IV Indolent Adult Non-Hodgkin Lymphoma
Ann Arbor Stage IV Marginal Zone Lymphoma
Ann Arbor Stage IV Small Lymphocytic Lymphoma

Interventions

DRUG: Lenalidomide
BIOLOGICAL: Rituximab

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]